3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase 4
2
Phase 2/3
2
Phase NA
1
Phase 2
1
Status
Withdrawn
1
Unknown
1
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
1
Conditions
Pain
5
Neoplasms
5
Pain, Intractable
3
Agnosia
3
Pain, Postoperative
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Spinal Stenosis
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Peripheral Nervous System Diseases
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain, Procedural
1
Neurotoxicity Syndromes
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mucositis
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Ketamine
3
Sodium Chloride
2
Ropivacaine
2
Propofol
2
Analgesics, Opioid
2
Analgesia, Patient-Controlled
2
parecoxib
1
Tea
1
Tapentadol
1
Surveys and Questionnaires
1
Sevoflurane
1
Saline Solution
1
Lidocaine
1
Ketorolac
1
Ibuprofen
1
Epinephrine
1
Dexamethasone
1
Codeine
1
Clonidine
1
Circumcision, Male
1
Celecoxib
1
Anesthesia, General
1
Acupuncture Therapy
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Agnosia
×
Ketamine
×
Clear all
NCT00210210
2025-09-19
KETAMINE
Institut Bergonié
Phase 3
Completed
230 enrolled
6 charts
NCT04621110
2021-04-01
NAIVe
University of Sao Paulo General Hospital
Phase 3
Unknown
60 enrolled
NCT01951911
2017-07-11
KETA-1
Haukeland University Hospital
Phase 3
Withdrawn